Posted on April 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on April 10, 20254/10/25
Unlock the Power of Indirect Treatment Comparisons (ITC) with Industry Experts
Posted on February 27, 20252/27/25
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
Posted on July 11, 20247/11/24
Key Insights from ARCS 2024: Shaping the Future of HTA and Reimbursement in Australia
Posted on March 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on October 17, 202310/17/23
Utilization of Indirect Treatment Comparison (ITC), External Control Arms (ECA) and Patient-Reported Outcome Measures (PROMs)
Posted on August 1, 20238/1/23
Commercial Key Success Factors (KSFs) for Global Drug Development Programs
Posted on April 17, 20234/17/23
What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry
Posted on October 12, 202210/12/22